Skip to main content

Abstract

This is a report on two cases of refractory schizophrenia and two cases of clozapine-resistant schizophrenia successful treated with paliperidone palmitate. To the authors’ knowledge, this is the first report of the successful use of paliperidone palmitate in such patients.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: e14 - e16
PubMed: 25716490

History

Received: 14 December 2013
Revision received: 8 February 2014
Accepted: 13 February 2014
Published ahead of print: 12 December 2014
Published in print: Winter 2015
Published online: 26 February 2015

Authors

Details

João Paulo Maia-de-Oliveira, M.D., M.Sc., Ph.D.
From the Hospital das Clínicas, Monte Alegre, Ribeirão Preto, São Paulo, Brazil; the University of São Paulo; the Dept. of Psychiatry, Federal University of São Paulo; and the Dept. of Neuroscience and Behavior, School of Medicine of Ribeirão Preto, São Paulo, Brazil.
Emerson Arcoverde Nunes, M.D.
From the Hospital das Clínicas, Monte Alegre, Ribeirão Preto, São Paulo, Brazil; the University of São Paulo; the Dept. of Psychiatry, Federal University of São Paulo; and the Dept. of Neuroscience and Behavior, School of Medicine of Ribeirão Preto, São Paulo, Brazil.
Juliana Mayumi Ushirohira, M.D.
From the Hospital das Clínicas, Monte Alegre, Ribeirão Preto, São Paulo, Brazil; the University of São Paulo; the Dept. of Psychiatry, Federal University of São Paulo; and the Dept. of Neuroscience and Behavior, School of Medicine of Ribeirão Preto, São Paulo, Brazil.
João Paulo Machado-de-Sousa, Ph.D.
From the Hospital das Clínicas, Monte Alegre, Ribeirão Preto, São Paulo, Brazil; the University of São Paulo; the Dept. of Psychiatry, Federal University of São Paulo; and the Dept. of Neuroscience and Behavior, School of Medicine of Ribeirão Preto, São Paulo, Brazil.
Rodrigo Affosenca Bressan, M.D., Ph.D.
From the Hospital das Clínicas, Monte Alegre, Ribeirão Preto, São Paulo, Brazil; the University of São Paulo; the Dept. of Psychiatry, Federal University of São Paulo; and the Dept. of Neuroscience and Behavior, School of Medicine of Ribeirão Preto, São Paulo, Brazil.
Jaime Eduardo Cecílio Hallak, M.D., Ph.D.
From the Hospital das Clínicas, Monte Alegre, Ribeirão Preto, São Paulo, Brazil; the University of São Paulo; the Dept. of Psychiatry, Federal University of São Paulo; and the Dept. of Neuroscience and Behavior, School of Medicine of Ribeirão Preto, São Paulo, Brazil.

Notes

Send correspondence to João Paulo Maia-de-Oliveira, M.D.; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share